Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Medtronic
US Department of Justice
UBS
Julphar
Chinese Patent Office
Harvard Business School
Farmers Insurance

Generated: June 22, 2018

DrugPatentWatch Database Preview

MELLARIL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Mellaril patents expire, and when can generic versions of Mellaril launch?

Mellaril is a drug marketed by Novartis and is included in two NDAs.

The generic ingredient in MELLARIL is thioridazine. There are eighteen drug master file entries for this compound. Additional details are available on the thioridazine profile page.
Summary for MELLARIL
Drug patent expirations by year for MELLARIL
Medical Subject Heading (MeSH) Categories for MELLARIL
Synonyms for MELLARIL
10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylthio)-10h-phenothiazinmono
10-(2-(1-methyl-2-piperidyl)ethyl)-2-(methylthio)-phenothiazinmonohydrochl
10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylthio)phenothiazine monohydrochloride
10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylthiophenothiazine hydrochloride
10-(2-(1-methyl-2-piperidyl)ethyl)-2-methylthiophenothiazinehydrochloride
10-(2-(1-methylpiperidin-2-yl)ethyl)-2-(methylthio)-10H-phenothiazine hydrochloride
10-[2-(1-Methyl-2-piperidinyl)ethyl]-2-(methylthio)-10H-phenothiazine hydrochloride
10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)phenothiazine hydrochloride
10-[2-(1-Methyl-2-piperidyl)-ethyl]-2-[methylthiol]-phenothiazine
10-[2-(1-methyl-2-piperidyl)-ethyl]-2-[methylthiol]-phenothiazine hydrochloride
10-[2-(1-Methyl-2-piperidyl)ethyl]-2-(methylthio)-10H-phenothiazine hydrochloride
10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine hydrochloride
10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylthiophenothiazine hydrochloride
10-[2-(1-methyl(2-piperidyl))ethyl]-2-methylthiophenothiazine, chloride
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine hydrochloride
10-[2-(1-Methylpiperidin-2-yl)ethyl]-2-(methylthio)-10H-phenothiazine Hydrochloride
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanyl-phenothiazine hydrochloride
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine hydrochloride
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine;hydrochloride
107388-89-6
10H-Phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylthio)-, monohydrochloride
1257-76-7
130-61-0
2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine hydrochloride
2-methylmercapto-10-(2-(n-methyl-2-piperidyl)ethyl)phenothiazinehydrochlorid
2-Methylmercapto-10-[2-(N-methyl-2-piperidyl)ethyl]phenothiazine hydrochloride
22857-EP2295421A1
22857-EP2315502A1
22857-EP2371810A1
22857-EP2371812A1
A806110
AB0013772
AC1L24JE
AC1Q3C6I
AK481323
AKOS015994763
Aldazine
AN-23047
AOB5375
API0024685
C21H26N2S2.HCl
C21H27ClN2S2
CAS-130-61-0
CCG-39270
CHEBI:48566
CHEMBL1200916
CPD000058380
CS-4450
CTK8G3443
D00798
DSSTox_CID_29360
DSSTox_GSID_49401
DSSTox_RID_83476
DTXSID9049401
EINECS 204-992-8
EU-0101252
FT-0631759
HMS1568O17
HMS1921E11
HY-B0965
I584
KS-00001859
KS-5108
labotest-bb lt00451961
LP01252
LS-105607
MCULE-1090059754
Mellaril (TN)
Mellaril hydrochloride
Melleril (tablet)
Melzine
MFCD00012655
MLS000028408
MLS001148599
MLS002222212
MolPort-001-727-928
NC00594
NCGC00094492-01
NCGC00094492-02
NCGC00094492-03
NCGC00094492-04
NCGC00094492-05
NCGC00260347-01
NCGC00261937-01
NSC 186060
NSC-186060
NSC-757349
NSC186060
NSC757349
Opera_ID_1713
OR20007
Pharmakon1600-01500575
Phenothiazine, 10-(2-(1-methyl-2-piperidyl)ethyl)-2-(methylthio)-, monohydrochloride
PL042892
Prestwick_437
Ridazine
SAM002564240
SBB057665
SCHEMBL41430
SMR000058380
Sonapax hydrochloride
SPECTRUM1500575
SR-01000000063
SR-01000000063-2
ST50412003
T 9025
Thioridazine (hydrochloride)
Thioridazine chloride
Thioridazine Hcl
Thioridazine hydrochloride
Thioridazine hydrochloride (JP17/USP)
Thioridazine hydrochloride [JAN]
Thioridazine hydrochloride [USP:JAN]
Thioridazine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Thioridazine hydrochloride intensol
Thioridazine hydrochloride, >=99%
Thioridazine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Thioridazine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Thioridazine.HCl
Tox21_202801
Tox21_501252
USAF SZ-3
USAF SZ-B
W-108347
WLN: T C666 BN ISJ ES1 B2-BT6NTJ A1 & GH
Z2784093622

US Patents and Regulatory Information for MELLARIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis MELLARIL thioridazine hydrochloride CONCENTRATE;ORAL 011808-012 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis MELLARIL thioridazine hydrochloride TABLET;ORAL 011808-009 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis MELLARIL thioridazine hydrochloride TABLET;ORAL 011808-016 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis MELLARIL thioridazine hydrochloride TABLET;ORAL 011808-017 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Moodys
Daiichi Sankyo
UBS
Julphar
Fuji
Express Scripts
Deloitte
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.